HomeCompareRGTPQ vs DIVO

RGTPQ vs DIVO: Dividend Comparison 2026

RGTPQ yields 1250.00% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RGTPQ wins by $135327077.56M in total portfolio value
10 years
RGTPQ
RGTPQ
● Live price
1250.00%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$135327077.59M
Annual income
$116,926,161,071,848.38
Full RGTPQ calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — RGTPQ vs DIVO

📍 RGTPQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRGTPQDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RGTPQ + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RGTPQ pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RGTPQ
Annual income on $10K today (after 15% tax)
$106,250.00/yr
After 10yr DRIP, annual income (after tax)
$99,387,236,911,071.11/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, RGTPQ beats the other by $99,387,236,910,236.69/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RGTPQ + DIVO for your $10,000?

RGTPQ: 50%DIVO: 50%
100% DIVO50/50100% RGTPQ
Portfolio after 10yr
$67663538.81M
Annual income
$58,463,080,536,415.03/yr
Blended yield
86.40%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RGTPQ buys
0
DIVO buys
0
No recent congressional trades found for RGTPQ or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRGTPQDIVO
Forward yield1250.00%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$135327077.59M$30.7K
Annual income after 10y$116,926,161,071,848.38$981.68
Total dividends collected$133960810.96M$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RGTPQ vs DIVO ($10,000, DRIP)

YearRGTPQ PortfolioRGTPQ Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$135,700$125,000.00$11,349$649.42+$124.4KRGTPQ
2$1,730,479$1,585,280.37$12,833$688.83+$1.72MRGTPQ
3$20,744,959$18,893,346.29$14,459$727.90+$20.73MRGTPQ
4$233,872,934$211,675,827.14$16,238$766.49+$233.86MRGTPQ
5$2,480,500,804$2,230,256,765.05$18,179$804.47+$2480.48MRGTPQ
6$24,761,170,753$22,107,034,892.35$20,293$841.71+$24761.15MRGTPQ
7$232,737,122,500$206,242,669,794.36$22,591$878.14+$232737.10MRGTPQ
8$2,060,741,008,119$1,811,712,287,044.72$25,087$913.65+$2060740.98MRGTPQ
9$17,197,118,239,637$14,992,125,360,949.39$27,791$948.18+$17197118.21MRGTPQ
10$135,327,077,588,260$116,926,161,071,848.38$30,718$981.68+$135327077.56MRGTPQ

RGTPQ vs DIVO: Complete Analysis 2026

RGTPQStock

RegenETP, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; and other tissue regeneration products. The company was formerly known as PolarityTE, Inc. and changed its name to RegenETP, Inc. in August 2023. RegenETP, Inc. is headquartered in Salt Lake City, Utah.

Full RGTPQ Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this RGTPQ vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RGTPQ vs SCHDRGTPQ vs JEPIRGTPQ vs ORGTPQ vs KORGTPQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.